Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Falciani

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Microbiology Spectrum|February 18, 2026
SET-M33 peptide as a selective <i>in vitro</i> antimicrobial agent against the porcine respiratory pathogen <i>Glaesserella parasuis</i>Ana Laura Pereira Lourenço, Oussama Rouam El Khatab, Chiara Falciani, et al.
Scientific Reports|May 10, 2025
The identity of implant materials governs the antimicrobial efficacy of SET-M33Alessia Maranesi, Sajad Mohammadi, Ismael Castañon, et al.
Frontiers in Cell and Developmental Biology|January 23, 2025
Targeting heparan sulfate proteoglycans as an effective strategy for inhibiting cancer cell migration and invasiveness compared to heparinLorenzo Depau, Jlenia Brunetti, Chiara Falciani, et al.
Chemistry & Biology|May 29, 2003
Rational design and molecular diversity for the construction of anti-alpha-bungarotoxin antidotes with high affinity and in vivo efficiencyLuisa Lozzi, Barbara Lelli, Ylenia Runci, et al.
Pharmaceutics|January 21, 2023
Inhalable Polymeric Nanoparticles for Pulmonary Delivery of Antimicrobial Peptide SET-M33: Antibacterial Activity and Toxicity In Vitro and In VivoLaura Cresti, Gemma Conte, Giovanni Cappello, et al.
Journal of Medicinal Chemistry|December 7, 2020
Heparan Sulfate Proteoglycans Can Promote Opposite Effects on Adhesion and Directional Migration of Different Cancer CellsLorenzo Depau, Jlenia Brunetti, Chiara Falciani, et al.
Frontiers in Oncology|October 18, 2019
Unraveling Heparan Sulfate Proteoglycan Binding Motif for Cancer Cell SelectivityJlenia Brunetti, Giulia Riolo, Lorenzo Depau, et al.
The Journal of Biological Chemistry|September 16, 2003
Synthetic peptides in the form of dendrimers become resistant to protease activityLuisa Bracci, Chiara Falciani, Barbara Lelli, et al.
Journal of Medicinal Chemistry|May 30, 2013
Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptorsChiara Falciani, Jlenia Brunetti, Barbara Lelli, et al.
Molecular Cancer Therapeutics|September 4, 2007
Synthesis and biological activity of stable branched neurotensin peptides for tumor targetingChiara Falciani, Monica Fabbrini, Alessandro Pini, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Microbiology Spectrum|February 18, 2026
SET-M33 peptide as a selective <i>in vitro</i> antimicrobial agent against the porcine respiratory pathogen <i>Glaesserella parasuis</i>Ana Laura Pereira Lourenço, Oussama Rouam El Khatab, Chiara Falciani, et al.
Scientific Reports|May 10, 2025
The identity of implant materials governs the antimicrobial efficacy of SET-M33Alessia Maranesi, Sajad Mohammadi, Ismael Castañon, et al.
Frontiers in Cell and Developmental Biology|January 23, 2025
Targeting heparan sulfate proteoglycans as an effective strategy for inhibiting cancer cell migration and invasiveness compared to heparinLorenzo Depau, Jlenia Brunetti, Chiara Falciani, et al.
Chemistry & Biology|May 29, 2003
Rational design and molecular diversity for the construction of anti-alpha-bungarotoxin antidotes with high affinity and in vivo efficiencyLuisa Lozzi, Barbara Lelli, Ylenia Runci, et al.
Pharmaceutics|January 21, 2023
Inhalable Polymeric Nanoparticles for Pulmonary Delivery of Antimicrobial Peptide SET-M33: Antibacterial Activity and Toxicity In Vitro and In VivoLaura Cresti, Gemma Conte, Giovanni Cappello, et al.
Journal of Medicinal Chemistry|December 7, 2020
Heparan Sulfate Proteoglycans Can Promote Opposite Effects on Adhesion and Directional Migration of Different Cancer CellsLorenzo Depau, Jlenia Brunetti, Chiara Falciani, et al.
Frontiers in Oncology|October 18, 2019
Unraveling Heparan Sulfate Proteoglycan Binding Motif for Cancer Cell SelectivityJlenia Brunetti, Giulia Riolo, Lorenzo Depau, et al.
The Journal of Biological Chemistry|September 16, 2003
Synthetic peptides in the form of dendrimers become resistant to protease activityLuisa Bracci, Chiara Falciani, Barbara Lelli, et al.
Journal of Medicinal Chemistry|May 30, 2013
Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptorsChiara Falciani, Jlenia Brunetti, Barbara Lelli, et al.
Molecular Cancer Therapeutics|September 4, 2007
Synthesis and biological activity of stable branched neurotensin peptides for tumor targetingChiara Falciani, Monica Fabbrini, Alessandro Pini, et al.
Pageof 8